Delivery Order SPE2DB22D3501-SPE2DB24FWL81
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,071.84 firm-fixed price delivery order is for the procurement of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,594 delivery order contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract has a firm fixed price and is set to expire on November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $15,594.00, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 2, 2024 and was awarded on August 1, 2024. This delivery...
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $32,854.08. The contract is a Firm Fixed Price Delivery Order with a completion date of May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.62 firm fixed-price contract, awarded on November 5, 2024, is for the delivery of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product, with a performance period through November 6, 2024. This is a delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,020.80, is for the delivery of GONAL-F RFF REDI-JECT 900 unit 1.5ML medical products. It is a firm-fixed-price delivery order contract with a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DX15D1022|SPE2DX23FVPYR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $51,516.67 firm fixed-price delivery order is for the pharmaceutical product GONAL-F RFF REDI-JECT 450 UNIT 0.75ML. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,296.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 units of GONAL-F, a specialty medication, with an ultimate completion date of October 16, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $5,728.44, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 29, 2021 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $32,925.00 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a period of performance through February 6, 2025. The contract has a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...